Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Findings from the Budget Calculator guide you in prioritizing goals and shaping a realistic plan. Use them to steer your financial journey.
20,466 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Robinhood Chain has posted $816,000 in gross revenue since its July 1 launch, with 89% going to Robinhood, 10% to Arb...
Ron Paul challenges President Trump’s move to hold government stakes in private companies, arguing it threatens liber...
LoanDepot moved to dismiss a West Capital Lending lawsuit in a California federal court, arguing the case lacks stand...
SpaceX sits at the edge of a dramatic valuation leap. This article explores a pivotal contract, the math behind a pos...
After the latest earnings, investors are weighing growth prospects, margins, and valuation for Domino's. This guide b...
Founders Fund has fully exited ETHZilla, and Peter Thiel has followed with a complete stake unload, underscoring a br...
Newity raises $11 million in a round led by CMT Digital as it eyes moving its small-business lending platform onto bl...
Transocean (Rig) 2025 earnings could hinge on fleet utilization and day rates. This guide unpackages the drivers, ris...
As AI-driven data center needs surge, Micron could defy typical cycles. This guide lays out why prediction: micron st...
Earnings season is a chance to gauge WLKP's momentum and risk. This guide shows investors how to read the WLKP report...
RE/MAX faces a changing housing landscape as it grows internationally. President Chris Lim outlines a strategy built ...